Suralap Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.45 M
as on 03-12-2024
- Paid Up Capital ₹ 2.45 M
as on 03-12-2024
- Company Age 30 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 99.72%
(FY 2020)
- Ebitda 99.89%
(FY 2020)
- Net Worth -0.01%
(FY 2020)
- Total Assets -0.00%
(FY 2020)
About Suralap Pharma
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.45 M and a paid-up capital of Rs 2.45 M, as per Ministry of Corporate Affairs (MCA) records.
Upender Kaushik and Indrdev Kumar serve as directors at the Company.
- CIN/LLPIN
U51219UP1995PTC100054
- Company No.
100054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1995
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Dehat, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Suralap Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upender Kaushik  | Director | 04-Apr-2024 | Current |
| Indrdev Kumar | Director | 04-Apr-2024 | Current |
Financial Performance of Suralap Pharma.
Suralap Pharma Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.72% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suralap Pharma?
In 2019, Suralap Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kaya Fragrance Private LimitedActive 21 years 3 monthsUpender Kaushik and Indrdev Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Suralap Pharma?
Unlock and access historical data on people associated with Suralap Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suralap Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suralap Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
